2016 – Federal Register Recent Federal Regulation Documents

On June 13, 2016, the Department of Commerce (the Department) published the preliminary results of the administrative review of the antidumping duty order on welded carbon steel standard pipe and tube products (welded pipe and tube) from Turkey. The period of review (POR) is May 1, 2014 through April 30, 2015. Based on our analysis of the comments received, we have made certain changes in the margin calculations. Therefore, the final results differ from the preliminary results. The final weighted-average dumping margins for the reviewed firms are listed below in the section entitled, ``Final Results of the Review.'' Further, we continue to find that Erbosan and Yucel Group had no reviewable shipments of subject merchandise during the POR.

The Commission hereby gives notice of the scheduling of expedited reviews pursuant to the Tariff Act of 1930 (``the Act'') to determine whether revocation of the countervailing duty order on sulfanilic acid from India and antidumping orders on sulfanilic acid from China and India would be likely to lead to continuation or recurrence of material injury within a reasonably foreseeable time.

The Food and Drug Administration (FDA) is announcing the issuance of an Emergency Use Authorization (EUA) (the Authorization) for an in vitro diagnostic device for detection of the Zika virus in response to the Zika virus outbreak in the Americas. FDA issued this Authorization under the Federal Food, Drug, and Cosmetic Act (the FD&C Act), as requested by Abbott Molecular, Inc. The Authorization contains, among other things, conditions on the emergency use of the authorized in vitro diagnostic device. The Authorization follows the February 26, 2016, determination by the Secretary of Health and Human Services (HHS) that there is a significant potential for a public health emergency that has a significant potential to affect national security or the health and security of U.S. citizens living abroad and that involves Zika virus. On the basis of such determination, the Secretary of HHS declared on February 26, 2016, that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection of Zika virus and/or diagnosis of Zika virus infection, subject to the terms of any authorization issued under the FD&C Act. The Authorization, which includes an explanation of the reasons for issuance, is reprinted in this document.

The Bureau of Land Management, Oklahoma Field Office, located at 7906 East 33rd Street, Suite 101, Tulsa, Oklahoma 74145, and the Moore Field Station, located at 200 Northwest 4th Street, Room 2401, Oklahoma City, Oklahoma 73102, will combine and relocate to 201 Stephenson Parkway, Suite 1200, Norman, Oklahoma 73072.

The Food and Drug Administration (FDA) has determined the regulatory review period for COSENTYX and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human biological product.

The Postal Service gives notice of filing a request with the Postal Regulatory Commission to add a domestic shipping services contract to the list of Negotiated Service Agreements in the Mail Classification Schedule's Competitive Products List.

The Department of Labor (DOL) is submitting Employment and Training Administration (ETA) sponsored information collection request (ICR) titled, ``Attestation by Employers Using Alien Crewmembers for Longshore Activities in U.S. Ports,'' to the Office of Management and Budget (OMB) for review and approval for continued use, without change, in accordance with the Paperwork Reduction Act of 1995 (PRA). Public comments on the ICR are invited.

This publication corrects a notice that was published in the Federal Register on December 6, 2016, 2016 Volume 81, Number 234, pages 87938-87939. The dates should read as follows:

The working group will meet via teleconference on January 10, 2017, from 1:00 p.m. to 3:30 p.m. Eastern Time.

We, the U.S. Fish and Wildlife Service, invite the public to comment on the following applications to conduct certain activities with endangered species, marine mammals, or both. With some exceptions, the Endangered Species Act (ESA) and Marine Mammal Protection Act (MMPA) prohibit activities with listed species unless Federal authorization is acquired that allows such activities.

The FAA is issuing this notice to advise the public of a meeting of Forty Sixth RTCA SC-224 Plenary.

In accordance with the Paperwork Reduction Act of 1995 (44 U.S.C. chapter 3501 et seq.), ED is proposing a new information collection.

This notice is issued in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant a partially exclusive, license in the United States to practice the inventions described and claimed in U.S. Patent No. 7,623,972 entitled ``Detection of Presence of Chemical Precursors''; U.S. Patent No. 7,801,687 entitled ``Chemical Sensors Using Coated Or Doped Carbon Nanotube Networks''; U.S. Patent No. 7,968,054 entitled ``Nanostructure Sensing and Transmission of Gas Data''; U.S. Patent No. 8,000,903 entitled ``Coated or Doped Carbon Nanotube Network Sensors as Affected by Environmental Parameters''; ARC-16292-1 entitled ``Nanosensor/Cell Phone Hybrid for Detecting Chemicals and Concentrations''; ARC-16902-1, entitled ``Nanosensor for Medical Diagnoses''; ARC-17110-1 entitled ``Detection of Gases and Vapors at Low Concentrations'' to ENDO Medical Inc., having its principal place of business at 2345 Yale Street, 1st Floor, Palo Alto, CA 94306. The patent rights in this invention have been assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. The prospective partially exclusive license will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.